In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintide–semaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results US$ 23.03 Min. order: 1 piece ★★★★★ 4.4 (49 reviews) Sold : Login>>
New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) Cagrilintide– Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) US$ 27.90 Min. order: 1 piece ★★★★★ 4.1 (252 reviews) Sold : Login>>
Cagrilintide/Semaglutide Blend 5mg/5mg US$ 21.48 Min. order: 1 piece ★★★★★ 4.5 (100 reviews) Sold : Login>>